テキサスにおける統合失調症の臨床試験
テキサス内の拠点で、統合失調症に関する34件の研究が参加者を募集しています。
テキサス内の都市
公式研究テキスト（英語）
Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
- Haracec Clinical Research, El Paso
- C-Trilogy Outreach, Longview
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/30更新 · NCT07101094A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
- Community Clinical Research, Inc., Austin
- Pillar Clinical Research, LLC, Richardson
被験者募集中第1相
18歳〜55歳 · 全性別 · 2026/09/28更新 · NCT07615426Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
- Local Institution - 0049, Austin
- Local Institution - 0194, Dallas
- Pillar Clinical Research - Richardson, Richardson
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/09/28更新 · NCT07686263NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Neurocrine Clinical Site, Austin
- Neurocrine Clinical Site, DeSoto
- Neurocrine Clinical Site, Houston
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/09/25更新 · NCT07114874Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
- Neurocrine Clinical Site, DeSoto
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/09/25更新 · NCT07227818Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Texas Research Group, Coppell
- PsyMed Solutions, Fort Worth
- Kaleidoscope Clinical Research, Houston
- 他3件
被験者募集中第3相
5歳〜17歳 · 全性別 · 2026/09/25更新 · NCT06229210Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia
- TG Therapeutics Investigational Trial Site, Richardson
被験者募集中第2相
18歳〜60歳 · 全性別 · 2026/09/23更新 · NCT07680946A Study of Brenipatide in Adult Participants With Schizophrenia
- Adams Clinical Dallas, DeSoto
- Re:Cognition Health - Fort Worth, Fort Worth
被験者募集中第2相
18歳〜55歳 · 全性別 · 2026/09/22更新 · NCT07410507A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Local Institution - 0149, Dallas
- VAST Clinical Research, Garland
- Local Institution - 0169, Houston
- 他2件
被験者募集中第3相
5歳〜17歳 · 全性別 · 2026/09/22更新 · NCT07424404A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Austin
被験者募集中第4相
18歳以上 · 全性別 · 2026/09/18更新 · NCT07105111A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
- Pillar Clinical Research, LLC, Richardson
被験者募集中第1相
18歳〜55歳 · 全性別 · 2026/09/17更新 · NCT07734493Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)
- The University of Texas Health Science Center, Houston, Houston
被験者募集中
22歳〜65歳 · 全性別 · 2026/09/16更新 · NCT05276050A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
- Community Clinical Research - Cross Park Drive /ID# 272977, Austin
- Pillar Clinical Research - Richardson /ID# 275715, Richardson
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/09/15更新 · NCT0714591852-week Open Label Safety-Tolerability Study
- Adams Clinical, DeSoto
- Pillar Clinical Research, Richardson
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/09/09更新 · NCT07369154A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
- VAST Clinical Research, Garland
- Local Institution - 0120, Houston
- Local Institution - 0066, Spring
被験者募集中第3相
13歳〜17歳 · 全性別 · 2026/09/04更新 · NCT07288567A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
- Community Clinical Research, Austin
被験者募集中第1相
18歳〜55歳 · 全性別 · 2026/09/02更新 · NCT07061288A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Austin
- Clinical Site, DeSoto
- Clinical Site, Richardson
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/09/01更新 · NCT07459647Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- Local Institution - 0016, Austin
- Local Institution - 0050, Dallas
- Local Institution - 0021, Fort Worth
- 他10件
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/19更新 · NCT07379827Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
- BioXcel Clinical Research Site, DeSoto
被験者募集中第1相
10歳〜17歳 · 全性別 · 2026/08/11更新 · NCT05025605Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia
- The University of Texas Health Science Center at Houston, Houston
被験者募集中
18歳〜60歳 · 全性別 · 2026/08/05更新 · NCT07060066Alternative Stimulation Mode and Location for Auditory Hallucination Neuromodulation Treatment
- The University of Texas Health Science Center at Houston, Houston
被験者募集中
18歳〜50歳 · 全性別 · 2026/08/03更新 · NCT02916810Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)
- The University of Texas Health Science Center, Houston, Houston
被験者募集中
18歳〜60歳 · 全性別 · 2026/07/07更新 · NCT06345963Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 2)
- The University of Texas Health Science Center, Houston, Houston
被験者募集中
18歳〜60歳 · 全性別 · 2026/07/07更新 · NCT06961916A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
- Community Clinical Research, Austin
被験者募集中第2相
18歳〜55歳 · 全性別 · 2026/06/23更新 · NCT07191483Deep Brain Stimulation for Psychosis
- UT Southwestern Medical Center, Dallas
被験者募集中
22歳〜70歳 · 全性別 · 2026/06/09更新 · NCT06257056A Study to Evaluate the Effect of KarXT on Urological Safety
- Local Institution - 0001, Austin
- InSite Clinical Research, DeSoto
被験者募集中第4相
18歳〜65歳 · 全性別 · 2026/06/03更新 · NCT07221877CLOZAPINE Response in Biotype-1
- UT Southwestern Medical Center, Dallas
被験者募集中第4相
18歳〜60歳 · 全性別 · 2026/05/11更新 · NCT04580134Database Registry for Neural Network Biomarkers in Psychosis
- University of Texas Southwestern Medical Center, Dallas
被験者募集中観察研究健康なボランティア歓迎
18歳〜60歳 · 全性別 · 2026/04/23更新 · NCT01409109Ocrelizumab for Psychosis by Autoimmunity
- Houston Methodist Research Institute, Houston
被験者募集中第1/2相
18歳〜35歳 · 全性別 · 2026/04/01更新 · NCT03971487Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- University of Texas Southwestern Medical Center, Dallas
被験者募集中観察研究
18歳〜40歳 · 全性別 · 2026/03/10更新 · NCT06740383NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Austin
- Neurocrine Clinical Site, DeSoto
- Neurocrine Clinical Site, Houston
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/03/06更新 · NCT06963034Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy
- University of Texas at Dallas, Dallas
被験者募集中
18歳〜65歳 · 全性別 · 2026/01/23更新 · NCT07098169Randomized Withdrawal Study in Patients With Schizophrenia
- Vanda Investigational Site, Austin
- Vanda Investigational Site, Houston
- Vanda Investigational Site, Irving
- 他1件
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/01/12更新 · NCT06961968Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- Reviva site, Austin
- Reviva site, Richardson
被験者募集中第3相健康なボランティア歓迎
18歳〜65歳 · 全性別 · 2024/12/19更新 · NCT05184335ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。